| Human protein reference database—2009 update TS Keshava Prasad, R Goel, K Kandasamy, S Keerthikumar, S Kumar, ... Nucleic acids research 37 (suppl_1), D767-D772, 2009 | 2492 | 2009 |
| A compendium of potential biomarkers of pancreatic cancer HC Harsha, K Kandasamy, P Ranganathan, S Rani, S Ramabadran, ... PLoS medicine 6 (4), e1000046, 2009 | 361 | 2009 |
| Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers MK Kashyap, A Marimuthu, CJH Kishore, S Peri, S Keerthikumar, ... Cancer biology & therapy 8 (1), 36-46, 2009 | 175 | 2009 |
| Different antioxidants status, total antioxidant power and free radicals in essential hypertension MK Kashyap, V Yadav, BS Sherawat, S Jain, S Kumari, M Khullar, ... Molecular and Cellular Biochemistry 277 (1), 89-99., 2005 | 147 | 2005 |
| Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery H Pawar, MK Kashyap, NA Sahasrabuddhe, S Renuse, HC Harsha, ... Cancer biology & therapy 12 (6), 510-522, 2011 | 146 | 2011 |
| Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS U Guha, R Chaerkady, A Marimuthu, AS Patterson, MK Kashyap, ... Proceedings of the National Academy of Sciences 105 (37), 14112-14117, 2008 | 140 | 2008 |
| Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B MK Kashyap, D Kumar, R Villa, JJ La Clair, C Benner, R Sasik, H Jones, ... Haematologica 100 (7), 945-954, 2015 | 95 | 2015 |
| SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome MK Kashyap, HC Harsha, S Renuse, H Pawar, NA Sahasrabuddhe, ... Cancer biology & therapy 10 (8), 796-810, 2010 | 94 | 2010 |
| Ulocuplumab (BMS-936564/MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. MK Kashyap, D Kumar, H Jones, CI Amaya-Chanaga, MY Choi, ... Oncotarget 7 (3), 2809-2822., 2016 | 88 | 2016 |
| SILAC‐based quantitative proteomic analysis of gastric cancer secretome A Marimuthu, Y Subbannayya, NA Sahasrabuddhe, L Balakrishnan, ... PROTEOMICS-Clinical Applications 7 (5-6), 355-366, 2013 | 80 | 2013 |
| Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma MK Kashyap, O Abdel-Rahman Molecular Cancer 17 (1), 54., 2018 | 77 | 2018 |
| Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats R Kh, M Khullar, M Kashyap, P Pandhi, R Uppal Journal of Hypertension 18 (7), 919-926., 2000 | 74 | 2000 |
| Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer D Telikicherla, A Marimuthu, MK Kashyap, YL Ramachandra, S Mohan, ... Clinical proteomics 9, 1-8, 2012 | 62 | 2012 |
| Temporal analysis of neural differentiation using quantitative proteomics R Chaerkady, CL Kerr, A Marimuthu, DS Kelkar, MK Kashyap, M Gucek, ... Journal of proteome research 8 (3), 1315-1326, 2009 | 61 | 2009 |
| Biochemical and molecular markers in renal cell carcinoma: an update and future prospects MK Kashyap, A Kumar, N Emelianenko, A Kashyap, R Kaushik, R Huang, ... Biomarkers 10 (4), 258-294., 2005 | 58 | 2005 |
| Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways X Wu, MS Zahari, B Ma, R Liu, S Renuse, NA Sahasrabuddhe, L Chen, ... Oncotarget 6 (30), 29143, 2015 | 56 | 2015 |
| Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia MK Kashyap, CI Amaya-Chanaga, D Kumar, B Simmons, N Huser, Y Gu, ... Journal of hematology & oncology 10, 1-16, 2017 | 53 | 2017 |
| The chronic lymphocytic leukemia microenvironment: beyond the B-cell receptor MY Choi, MK Kashyap, D Kumar Best Practice & Research Clinical Haematology 29 (1), 40-53, 2016 | 51 | 2016 |
| Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19 P Kumar, AK Sah, G Tripathi, A Kashyap, A Tripathi, R Rao, PC Mishra, ... Molecular and Cellular Biochemistry 476 (2), 553-574, 2021 | 45 | 2021 |
| Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel … X Zhang, T Maity, MK Kashyap, M Bansal, A Venugopalan, S Singh, ... Molecular & Cellular Proteomics 16 (5), 891-910, 2017 | 41 | 2017 |
